Related Experiment Video

Updated: May 2, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K

Infections caused by Chlamydophila pneumoniae

Irena Choroszy-Król1, Magdalena Frej-Mądrzak, Martyna Hober

  • 1Department of Basic Sciences, Faculty of Health Science, Wroclaw Medical University, Poland.

Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University
|March 6, 2014
PubMed

Insights

Chlamydophila pneumoniae frequently causes respiratory tract infections (RTI) and is linked to bronchial asthma and chronic obstructive pulmonary disease (COPD) exacerbations. Its role in other non-communicable diseases like atherosclerosis and lung cancer is under investigation.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Chlamydophila pneumoniae is a common cause of respiratory tract infections (RTI), including pharyngitis, sinusitis, bronchitis, and pneumonia.
  • This bacterium has a high affinity for the airway epithelium, contributing to its prevalence in respiratory illnesses.
  • Chlamydophila pneumoniae is estimated to be responsible for approximately 20% of lower respiratory tract infections.

Purpose of the Study:

  • To review the role of Chlamydophila pneumoniae in various respiratory and non-communicable diseases.
  • To highlight the bacterium's involvement in the pathogenesis of bronchial asthma and exacerbations of chronic obstructive pulmonary disease (COPD).
  • To explore the emerging connections between Chlamydophila pneumoniae infection and conditions such as atherosclerosis, lung cancer, and neurodegenerative diseases.

Main Methods:

  • Literature review of studies investigating Chlamydophila pneumoniae infections.
  • Analysis of epidemiological data on the prevalence of Chlamydophila pneumoniae in RTIs and other diseases.
  • Synthesis of current research on the pathogenic mechanisms and clinical associations of Chlamydophila pneumoniae.

Main Results:

  • Chlamydophila pneumoniae is a significant etiological agent of various RTIs.
  • The infection is implicated in the development and progression of bronchial asthma and contributes to 4-16% of COPD exacerbations.
  • Emerging evidence suggests a link between Chlamydophila pneumoniae and atherosclerosis, lung cancer, arthritis, Alzheimer's disease, multiple sclerosis, sarcoidosis, and erythema nodosum, though its role is not fully elucidated.

Conclusions:

  • Chlamydophila pneumoniae is a key pathogen in respiratory infections with implications for chronic respiratory diseases.
  • Further research is needed to fully understand the bacterium's role in the pathogenesis of a spectrum of non-communicable diseases.
  • Recognizing Chlamydophila pneumoniae's broad impact is crucial for diagnosis and management of related health conditions.

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

8.6K
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

3.1K

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
842
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K